Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Debiopharm (Switzerland) | Researchclopedia

Back to institutions

Debiopharm (Switzerland)

Lausannecompany

368

Works

25,196

Citations

87

h-index

Top Research Topics

Cell death mechanisms and regulation Signaling Pathways in Disease Cancer Treatment and Pharmacology

Top Researchers

Pierre J. Magistretti Tamedia (Switzerland)

739 works53,685 citationsh-index: 105

Recent Research

Challenges and Potential Solutions to Advance Global Cancer Drug Development

Axel Glasmacher,Kim Lyerly,et al.

20260 citations

Hepatitis C virus research

Fibroblast Growth Factor Research

Peptidase Inhibition and Analysis

Cancer Immunotherapy and Biomarkers

RNA Interference and Gene Delivery

Lung Cancer Treatments and Mutations

Advanced Drug Delivery Systems

Monoclonal and Polyclonal Antibodies Research

Head and Neck Cancer Studies

Theodore S. Lawrence University of Michigan

1,308 works43,007 citationsh-index: 102

Guido Cavaletti Bellvitge University Hospital

790 works25,030 citationsh-index: 85

Eva Herrmann Goethe University Frankfurt

940 works24,539 citationsh-index: 80

Paolo Nucíforo Vall d'Hebron Institute of Oncology

836 works19,387 citationsh-index: 70

Yangjie Wu East China University of Science and Technology

744 works13,302 citationsh-index: 57

Model-based quantification of immune response and anti-staphylococcal activity of afabicin in immunocompetent mouse thigh infections to enable predictions of clinical efficacy

R. Saporta,Elisabet I. Nielsen,et al.

20260 citations

A phase 1/2 study to assess peptidomimetic carbonic anhydrase IX imaging and therapy with [ <sup>68</sup> Ga]Ga-DPI-4452 and [ <sup>177</sup> Lu]Lu-DPI-4452 in patients with advanced clear cell renal cell carcinoma and other solid tumors.

Michael S. Hofman,Francoise Kraeber-Bodere,et al.

20260 citations

Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of [ <sup>14</sup> C]Xevinapant, a Potent, Oral, Small‐Molecule IAP Inhibitor

Annick Ménétrey,Valerie Nicolas‐Métral,et al.

20260 citations

Identification, structural elucidation and nonclinical characterisation of oxMET1: a further major metabolite of xevinapant?

Benedikt Lang,Hanno Schieferstein,et al.

20260 citations

PCR127 Identifying Patient-Reported Outcome Measures to Capture Patients’ Experiences of Symptoms and Impacts of Myelodysplastic Syndromes (MDS)

Nicolas Plommet,Isabelle Petit,et al.

20250 citations